Home
Our Focus
Overview
Literature & Publications
Pipeline
Overview
Acute Ischemic Stroke
Preeclampsia
Clinical Trials
Overview
Acute Ischemic Stroke
Preeclampsia
ReMEDy2 Trial
Overview
About ReMEDy2
Stroke Disease
For Physicians
Trial Locations
About DiaMedica
Overview
Leadership
Careers
Contact
Investors Relations
Overview
Press Releases
Events & Presentations
Stock Data
Analyst Coverage
Financial Reports & SEC Filings
Governance
Resources
SEC Filings
Investors Relations
Investors Relations
Overview
Press Releases
Events & Presentations
Stock Data
Nasdaq Quote
Charts
Historical Data
Analyst Coverage
Financial Reports & SEC Filings
SEC Filings
Annual Reports
Tax Information (PFIC)
Governance
Board of Directors
Board Committees
Governance Documents
Resources
Investor Contact
FAQ
Share Consolidation Instructions
Email Alerts
Financial Reports & SEC Filings
SEC Filings
Annual Reports
Tax Information (PFIC)
Filing Type:
View All
10-K
10-K/A
10-Q
144
20FR12B
20FR12B/A
3
4
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
REGDEX
RW
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2014
2007
Date
Form
Description
PDF
XBRL
Pages
09/17/18
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-10.5
EX-10.6
169
09/04/18
UPLOAD
SEC-generated letter
Documents
TEXT-EXTRACT
2
08/27/18
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-3.1
EX-3.2
EX-3.4
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-4.5
EX-4.6
EX-4.7
EX-4.8
EX-4.9
EX-4.10
EX-4.11
EX-4.12
EX-4.13
EX-4.14
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-21.1
486
04/17/18
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
04/03/18
RW
Registration Withdrawal Request
2
03/11/14
20FR12B/A
Form for initial registration of a class of securities of foreign private issuers pursuant to section 12(b)
Documents
EX-4.6
EX-4.7
EX-15.1
215
01/30/14
20FR12B
Form for initial registration of a class of securities of foreign private issuers pursuant to section 12(b)
Documents
EX-1.1
EX-1.2
EX-1.3
EX-1.4
EX-1.5
EX-2.1
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-4.5
EX-8.1
240
05/16/07
REGDEX
Notice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933]
9
Previous
1…
25
26
27
28
29
30
31
32
33
34
Email Alerts
Contacts
RSS News Feed